771
Participants
Start Date
June 1, 2017
Primary Completion Date
July 2, 2018
Study Completion Date
July 31, 2018
FMX103 minocycline foam 1.5%
Dosage form description: Foam containing minocycline HCl 1.5%. Once daily application of a sufficient amount of foam to cover the entire face. Estimated maximum is 0.5 g of drug product containing 7.5 mg (1.5% active) of minocycline. Participants will apply a small amount of the drug as a thin layer over all areas of the face. Participants should apply the drug at approximately the same time each day, about 1 hour before bedtime.
Vehicle foam
Dosage form description: Foam containing minocycline vehicle foam. Once daily application of a sufficient amount of foam to cover the entire face. Estimated maximum is 0.5 g of drug product containing 0.0 mg (vehicle) of minocycline. Participants will apply a small amount of the drug as a thin layer over all areas of the face. Participants should apply the drug at approximately the same time each day, about 1 hour before bedtime.
Foamix Investigational Site # 224, Exton
Foamix Investigational Site # 216, Lynchburg
Foamix Investigational Site # 238, High Point
Foamix Investigational Site # 212, Raleigh
Foamix Investigational Site # 230, Mt. Pleasant
Foamix Investigational Site #245, DeLand
Foamix Investigational Site #247, Hialeah
Foamix Investigational Site #252, Hialeah
Foamix Investigational Site # 214, Miami
Foamix Investigational Site # 241, North Miami Beach
Foamix Investigational Site #246, Miami
Foamix Investigational Site # 215, Boynton Beach
Foamix Investigational Site # 223, Boca Raton
Foamix Investigational Site # 240, Fort Myers
Foamix Investigational Site #248, Oldsmar
Foamix Investigational Site # 228, Knoxville
Foamix Investigational Site # 235, Louisville
Foamix Investigational Site # 237, Louisville
Foamix Investigational Site #243, Plainfield
Foamix Investigational Site # 218, South Bend
Foamix Investigational Site # 225, Newburgh
Foamix Investigational Site # 210, Detroit
Foamix Investigational Site # 232, Fridley
Foamix Investigational Site # 211, Arlington Heights
Foamix Investigational Site # 202, Hot Springs
Foamix Investigational Site # 222, Rogers
Foamix Investigational Site # 236, Norman
Foamix Investigational Site # 219, Arlington
Foamix Investigational Site # 201, Houston
Foamix Investigational Site # 209, Webster
Foamix Investigational Site # 208, San Antonio
Foamix Investigational Site # 213, San Antonio
Foamix Investigational Site # 204, Newnan
Foamix Investigational Site # 206, Pflugerville
Foamix Investigational Site # 227, Denver
Foamix Investigational Site # 207, Glendale
Foamix Investigational Site # 226, Los Angeles
Foamix Investigational Site #244, Encino
Foamix Investigational Site #251, North Hollywood
Foamix Investigational Site #250, San Marcos
Foamix Investigational Site # 217, San Diego
Foamix Investigational Site # 220, Murrieta
Foamix Investigational Site # 239, Temecula
Foamix Investigational Site #249, Huntington Beach
Foamix Investigational Site # 203, Seattle
Foamix Investigational Site # 229, Watertown
Collaborators (1)
Premier Research Group plc
UNKNOWN
Vyne Therapeutics Inc.
INDUSTRY